Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788306

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788306

Pulsed Field Ablation

PUBLISHED:
PAGES: 174 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Pulsed Field Ablation Market to Reach US$6.0 Billion by 2030

The global market for Pulsed Field Ablation estimated at US$985.9 Million in the year 2024, is expected to reach US$6.0 Billion by 2030, growing at a CAGR of 34.9% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 37.2% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Generators segment is estimated at 28.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$259.2 Million While China is Forecast to Grow at 33.0% CAGR

The Pulsed Field Ablation market in the U.S. is estimated at US$259.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$885.0 Million by the year 2030 trailing a CAGR of 33.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 32.2% and 30.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.1% CAGR.

Global Pulsed Field Ablation Market - Key Trends & Drivers Summarized

How Is Pulsed Field Ablation Reshaping Cardiac Electrophysiology?

Pulsed Field Ablation (PFA) is revolutionizing the field of cardiac electrophysiology by offering a safer and more precise alternative to traditional thermal ablation techniques for treating atrial fibrillation (AF). Unlike radiofrequency (RF) or cryoablation, which use heat or extreme cold to destroy malfunctioning heart tissue, PFA employs high-voltage electrical pulses to selectively target cardiac cells while minimizing collateral damage to surrounding structures. This non-thermal approach significantly reduces the risk of complications such as esophageal injury, phrenic nerve damage, and pulmonary vein stenosis, making PFA a game-changing technology in AF treatment. The increasing prevalence of atrial fibrillation, fueled by aging populations and rising cardiovascular disease rates, has heightened the demand for innovative and minimally invasive treatment solutions. As clinical trials continue to demonstrate superior safety profiles and efficiency with PFA, more electrophysiologists are embracing this technology, marking a shift in the standard of care for AF patients worldwide.

What Technological Advancements Are Driving the Growth of Pulsed Field Ablation?

The development of advanced catheter designs and energy delivery systems has propelled the adoption of pulsed field ablation in interventional cardiology. Modern PFA catheters feature multi-electrode arrays that allow for precise, rapid, and uniform energy delivery, reducing procedure times and enhancing treatment efficacy. Integration with real-time imaging and mapping technologies has further improved accuracy, enabling electrophysiologists to create detailed cardiac tissue models for targeted ablation. Additionally, AI-driven software solutions are being incorporated into PFA systems to optimize pulse sequences and energy delivery, ensuring personalized treatment plans for patients. The introduction of catheter-based PFA systems with variable pulse modulation capabilities is expanding its applications beyond atrial fibrillation, with ongoing research exploring its potential for ventricular arrhythmias and other electrophysiological disorders. As device manufacturers focus on improving catheter flexibility, safety, and energy efficiency, PFA is expected to become a cornerstone in modern cardiac ablation therapy.

Why Are Electrophysiologists and Healthcare Providers Shifting Toward Pulsed Field Ablation?

The adoption of pulsed field ablation is rapidly increasing among electrophysiologists due to its ability to provide faster, safer, and more effective treatment for atrial fibrillation. Traditional thermal ablation techniques require extensive operator experience to balance lesion effectiveness and safety, whereas PFA’s tissue-selective mechanism simplifies the ablation process, reducing procedural complexity and improving outcomes. Additionally, PFA procedures have demonstrated shorter recovery times and lower complication rates, making them attractive for both patients and healthcare providers. Hospitals and specialized cardiac centers are investing in PFA technology as part of broader initiatives to enhance electrophysiology services and improve patient care. The growing body of clinical evidence supporting PFA’s long-term efficacy and safety is also influencing regulatory approvals and reimbursement policies, encouraging wider adoption in both private and public healthcare systems. As healthcare providers seek to minimize procedural risks and optimize patient outcomes, PFA is emerging as the preferred approach for catheter ablation procedures.

What Are the Key Growth Drivers of the Pulsed Field Ablation Market?

The growth in the global pulsed field ablation market is driven by several factors, including rising atrial fibrillation cases, increasing demand for minimally invasive cardiac procedures, and continuous advancements in ablation catheter technology. The shift toward non-thermal energy sources for cardiac ablation has positioned PFA as a disruptive innovation in electrophysiology, leading to increased investments from medical device manufacturers and research institutions. Expanding healthcare infrastructure in emerging markets, coupled with growing physician awareness and training programs, is further accelerating PFA adoption. The availability of clinical data supporting PFA’s safety and efficacy, along with favorable regulatory frameworks in key markets, is enhancing its commercial viability. Additionally, collaborations between healthcare providers and device manufacturers are driving innovation in catheter design, energy delivery, and procedural workflow optimization. As hospitals and cardiac centers expand their electrophysiology capabilities, the demand for PFA systems is expected to rise, solidifying its role as a leading technology in cardiac ablation therapy.

SCOPE OF STUDY:

The report analyzes the Pulsed Field Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Catheters, Generators); Indication (Atrial Fibrillation, Non-atrial Fibrillation); End-Use (Inpatient Facilities, Outpatient Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • AccuPulse Medical
  • Acutus Medical
  • Adagio Medical
  • AngioDynamics
  • Arga Medtech
  • AtriAN Medical
  • AtriCure
  • Biotronik
  • Boston Scientific
  • CardioFocus
  • CathRx
  • Civitas Health
  • ElectroPhysiology Frontiers
  • Elekta
  • EnChannel Medical
  • Galvanize Therapeutics
  • Gradient Medical
  • Hangzhou Dinova EP Technology
  • Hansen Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32730

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulsed Field Ablation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation Throws the Spotlight on Pulsed Field Ablation as a Next-Generation Treatment Modality
    • Growing Clinical Preference for Non-Thermal Ablation Technologies Drives Adoption of Pulsed Field Energy Platforms
    • Expansion of Electrophysiology Labs and Cardiac Centers Strengthens Business Case for Advanced Ablation Systems
    • Increased Risk of Collateral Damage with Conventional RF and Cryoablation Spurs Transition to Pulsed Field Approaches
    • Positive Outcomes from Clinical Trials and Real-World Registries Generate Confidence in Efficacy and Safety of Pulsed Field Ablation
    • Technological Advancements in Multielectrode Catheters Propel Development of Single-Shot and Rapid PFA Procedures
    • Regulatory Approvals and CE Markings for First-in-Class Devices Drive Early Commercialization in Europe and Global Markets
    • Surging Investment in Electrophysiology by MedTech Giants Fuels Innovation and Market Entry of Pulsed Field Devices
    • Rising Geriatric Population and Burden of Cardiac Arrhythmias Expands Demand for Safe and Minimally Invasive Ablation Techniques
    • Focus on Procedure Efficiency and Reduced Anesthesia Time Strengthens Market for Outpatient-Based PFA Systems
    • Integration of AI and Real-Time Imaging with PFA Platforms Enhances Precision and Reduces Operator Variability
    • Emergence of Reversible Electroporation Mechanisms Enhances Tissue Selectivity and Minimizes Esophageal and Phrenic Nerve Injury
    • Growing Use of Pulsed Field Ablation in Paroxysmal and Persistent AF Drives Broader Indication Expansion
    • Collaborations Between Hospitals and Device Companies Accelerate Adoption Through Investigator-Led Clinical Programs
    • Increased Focus on Pulmonary Vein Isolation with Minimal Thermal Footprint Supports Next-Gen AF Treatment Paradigms
    • Development of Compact, Fully Integrated PFA Systems Enhances Usability and Expands Adoption in Community Hospitals
    • Favorable Reimbursement Trends for AF Ablation Procedures Drive Economic Justification for Technology Migration to PFA
    • Rising Awareness Among Electrophysiologists About Safety Advantages Over Thermal Techniques Spurs Training and Usage
    • Globalization of Clinical Studies and Regulatory Harmonization Strengthens Pipeline Activity and Market Access for PFA Devices
    • Entry of New Market Players and Startups Encourages Competitive Innovation in Energy Delivery and Catheter Design
    • Surge in Demand for Personalized Cardiac Care and Targeted Ablation Therapy Sustains Long-Term Growth for Pulsed Field Ablation
    • Barriers in Cross-Modality Comparisons and Long-Term Follow-Up Create Opportunities for Robust Evidence Generation and Clinical Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulsed Field Ablation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulsed Field Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Generators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Generators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Non-atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Non-atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Inpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Inpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Outpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 17: USA 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • JAPAN
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • CHINA
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • EUROPE
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Pulsed Field Ablation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • FRANCE
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 48: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • GERMANY
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 54: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Germany 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • ITALY
    • TABLE 60: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Italy 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 66: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: UK 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulsed Field Ablation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 84: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Component - Catheters and Generators - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of World 6-Year Perspective for Pulsed Field Ablation by Component - Percentage Breakdown of Value Sales for Catheters and Generators for the Years 2025 & 2030
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by Indication - Atrial Fibrillation and Non-atrial Fibrillation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulsed Field Ablation by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation and Non-atrial Fibrillation for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulsed Field Ablation by End-Use - Inpatient Facilities and Outpatient Facilities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulsed Field Ablation by End-Use - Percentage Breakdown of Value Sales for Inpatient Facilities and Outpatient Facilities for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!